Back to MMP Insights
How VJHemOnc covered multiple myeloma advances throughout 2025

How VJHemOnc covered multiple myeloma advances throughout 2025

14 April 2026

How VJHemOnc covered multiple myeloma advances throughout 2025

The field of multiple myeloma (MM) is evolving at a remarkable pace, with new therapeutic classes, novel combinations, and rapidly advancing technologies that are reshaping the treatment landscape. For healthcare professionals (HCPs), keeping up to date with these developments has become increasingly difficult, which makes independent medical education (IME) crucial. In 2025, VJHemOnc reinforced its commitment to supporting the global MM HCP community by delivering open-access, expert-driven updates and trial results from the year’s most important scientific congresses.

A video-first approach to IME

At VJHemOnc, our aim is to bring HCPs closer to the experts shaping the field. Our video-first model allows our audience to hear directly from leading investigators and thought leaders, offering real-time interpretation of emerging data and the context needed to understand how new findings may influence practice.

Using this approach helps to accelerate knowledge dissemination, encourage the adoption of breakthrough treatments, and ultimately support better patient outcomes worldwide.

Throughout 2025, the team captured hundreds of myeloma-focused expert interviews, editorial insights, and focused discussions, ensuring clinicians everywhere, regardless of geography, schedule, or congress attendance, could access high-quality, independent updates.


Congress coverage

This year, VJHemOnc provided coverage across 10 key myeloma-relevant meetings, including some of the largest pan-disease congresses in the hematology space:

EHA

SOHO

ASH

ASCO

EBMT

The EHA-EBMT European CAR T-cell Meeting

SOHO Italy

 

As well as myeloma-specific events:

IMS

COMy

Oxford Myeloma Workshop

 

And six scientific workshops organized by the events arm of Magdalen Medical Publishing, Magdalen Scientific :

IBC

iwCAR-T

iwMyeloma

Miami Myeloma MRD

iwGPRC5D

iwHRMM

 

Accessing the MM congress coverage

All the 2025 content and more is available on the Multiple Myeloma channel . This open-access educational platform offers HCPs resources in a range of formats, including expert video interviews, roundtable discussions, podcasts, and feature articles.

Content has been organized to help users quickly find the information they want. For clinicians wanting snapshots from a meeting, each congress has a dedicated page; while for those focused on a specific clinical question or theme, content is organized by topic, including MRD, real-world data, and immuno-oncology. Click here to explore the resources on the Multiple Myeloma Channel.

 

If you are interested in supporting the Multiple Myeloma channel and VJHemOnc’s extensive congress coverage, please get in touch with our team.

layout-background
TERMS OF USEPRIVACY POLICYCOOKIE POLICYSITEMAP

© 2026 MAGDALEN MEDICAL PUBLISHING. ALL RIGHTS RESERVED.

Magdalen Medical Publishing Ltd is a company registered in England and Wales (company no. 09997585, vat no. 247098678), the Oxford Science Park, Magdalen Centre, Oxford, OX4 4GA